Acneiform Eruptions Follow-up

  • Author: Julianne H Kuflik, MD; Chief Editor: Dirk M Elston, MD   more...
 
Updated: Mar 26, 2012
 

Patient Education

For patient education resources, see the Skin, Hair, and Nails Center; Teen Health Center and Sexually Transmitted Diseases Center, as well as Acne and Syphilis.

 
Contributor Information and Disclosures
Author

Julianne H Kuflik, MD  Assistant Clinical Professor of Dermatology, Department of Dermatology, UMDNJ-New Jersey Medical School

Julianne H Kuflik, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Coauthor(s)

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Specialty Editor Board

Robin Travers, MD  Assistant Professor of Medicine (Dermatology), Dartmouth University School of Medicine; Staff Dermatologist, New England Baptist Hospital; Private Practice, SkinCare Physicians

Robin Travers, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Informatics Association, Massachusetts Medical Society, Medical Dermatology Society, and Women's Dermatologic Society

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Jeffrey Meffert, MD  Assistant Clinical Professor of Dermatology, University of Texas School of Medicine at San Antonio

Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, and Texas Dermatological Society

Disclosure: Nothing to disclose.

Glen H Crawford, MD  Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital

Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD  Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References

  1. Józwiak S, Schwartz RA, Janniger CK, Michalowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. Dec 1998;37(12):911-7. [Medline].

  2. Song MG, Park KB, Lee ES. Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner. Dermatol Surg. Dec 1999;25(12):970-3. [Medline].

  3. Harden D, Keeling JH. Papular and nodular lesions of the scalp, face, and neck. Secondary syphilis. Arch Dermatol. Aug 1997;133(8):1027, 1030. [Medline].

  4. Lambert WC, Bagley MP, Khan Y, Schwartz RA. Pustular acneiform secondary syphilis. Cutis. Jan 1986;37(1):69-70. [Medline].

  5. Kusuhara M, Hachisuka H, Sasai Y. Statistical survey of 150 cases with sporotrichosis. Mycopathologia. May 1988;102(2):129-33. [Medline].

  6. Goyal T, Varshney A, Bakshi SK. Familial atrophia maculosa varioliformis cutis: First case report from the Indian subcontinent with pedigree analysis. Indian J Dermatol Venereol Leprol. Mar 2012;78(2):182-5. [Medline].

  7. Held JL, Andrew JE, Toback AC. Eruptive vellus hair cysts. Cutis. Sep 1987;40(3):259-60. [Medline].

  8. Fung MA, Berger TG. A prospective study of acute-onset steroid acne associated with administration of intravenous corticosteroids. Dermatology. 2000;200(1):43-4. [Medline].

  9. Hurwitz RM. Steroid acne. J Am Acad Dermatol. Dec 1989;21(6):1179-81. [Medline].

  10. Farella V, Sberna F, Knöpfel B, Urso C, Difonzo EM. Acne-like eruption caused by amineptine. Int J Dermatol. Dec 1996;35(12):892-3. [Medline].

  11. Grimalt R, Mascaró-Galy JM, Ferrando J, Lecha M. Guess what? Macronodular iatrogenic acne due to amineptine. Eur J Dermatol. Sep 1999;9(6):491-2. [Medline].

  12. Vexiau P, Gourmel B, Castot A, Husson C, Rybojad M, Julien R, et al. Severe acne due to chronic amineptine overdose. Arch Dermatol Res. 1990;282(2):103-7. [Medline].

  13. Schalock PC, Zug KA. Acneiform reaction to erlotinib. Dermatitis. Dec 2007;18(4):230-1. [Medline].

  14. Eames T, Landthaler M, Karrer S. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor. Eur J Dermatol. Nov-Dec 2007;17(6):552-3. [Medline].

  15. Gencoglan G, Ceylan C. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Skin Pharmacol Physiol. 2007;20(5):260-2. [Medline].

  16. DeWitt CA, Siroy AE, Stone SP. Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. J Am Acad Dermatol. Mar 2007;56(3):500-5. [Medline].

  17. Santoro F, Cozzani E, Parodi A. Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor. J Dermatolog Treat. 2006;17(3):160-1. [Medline].

  18. Journagan S, Obadiah J. An acneiform eruption due to erlotinib: prognostic implications and management. J Am Acad Dermatol. Feb 2006;54(2):358-60. [Medline].

  19. Myskowski PL, Halpern AC. Skin reactions to the new biologic anticancer drugs. Curr Opin Support Palliat Care. Dec 2009;3(4):294-9. [Medline].

  20. Sherertz EF. Acneiform eruption due to "megadose" vitamins B6 and B12. Cutis. Aug 1991;48(2):119-20. [Medline].

  21. Monk B, Cunliffe WJ, Layton AM, Rhodes DJ. Acne induced by inhaled corticosteroids. Clin Exp Dermatol. Mar 1993;18(2):148-50. [Medline].

  22. Adams BB, Chetty VB, Mutasim DF. Periorbital comedones and their relationship to pitch tar: a cross-sectional analysis and a review of the literature. J Am Acad Dermatol. Apr 2000;42(4):624-7. [Medline].

  23. Adams BB, Mutasim DF. Pustular eruption induced by olanzapine, a novel antipsychotic agent. J Am Acad Dermatol. Nov 1999;41(5 Pt 2):851-3. [Medline].

  24. Bogdanowski T, Rubisz-Brzezinska J. [Giant nevus comedonicus]. Przegl Dermatol. Jul-Aug 1988;75(4):305-7. [Medline].

  25. Borton LK, Schwartz RA. Pityrosporum folliculitis: a common acneiform condition of middle age. Ariz Med. Aug 1981;38(8):598-601. [Medline].

  26. Choi MJ, Kim JW, Koh BK. Solitary premature sebaceous hyperplasia associated with acneiform eruption. Acta Derm Venereol. 2004;84(6):483-4. [Medline].

  27. Cotena C, Gisondi P, Colato C, Girolomoni G. Acneiform eruption induced by cetuximab. Acta Dermatovenerol Croat. 2007;15:246-248. [Medline].

  28. del Río E. Peculiar distribution of comedones: a report of three cases. Dermatology. 1997;195(2):162-3. [Medline].

  29. Demitsu T, Kosuge A, Yamada T, Usui K, Katayama H, Yaoita H. Acute generalized exanthematous pustulosis induced by dexamethasone injection. Dermatology. 1996;193(1):56-8. [Medline].

  30. Forstinger C, Kittler H, Binder M. Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol. Nov 1999;41(5 Pt 1):775-7. [Medline].

  31. Kanzaki T. Acneiform eruption induced by lithium carbonate. J Dermatol. Aug 1991;18(8):481-3. [Medline].

  32. Kogan BG, Stepanenko VI, Gorgol VT. Substantiation of a rational system of examination algorithms and standards of comprehensive treatment of patients with rosacea, demodecosis and perioral dermatitis. Ukrainian J Dermatol Venereol. 2003;2(9):17-27.

  33. Lee S, Park SG, Lee MG. Chloracne with acantholytic dyskeratosis associated with herbicides: A new histological variant?. J Am Acad Dermatol. Apr 2004;50(4):E8. [Medline].

  34. Lefkowitz A, Schwartz RA, Lambert WC. Nevus comedonicus. Dermatology. 1999;199(3):204-7. [Medline].

  35. Marks R, Black MM. Perioral dermatitis. A histopathologic study of 26 cases. Br J Dermatol. Mar 1971;84(3):242-7. [Medline].

  36. Moloney FJ, Egan CA. Case 3. Acne agminata (lupus miliaris disseminatus faciei). Clin Exp Dermatol. Nov 2003;28(6):685-6. [Medline].

  37. Mori R, Matsushima S, Honda T, Horiguchi Y, Imamura S. Chronic superficial pyoderma of the face: an unusual male case of rosacea fulminans. J Dermatol. Mar 2005;32(3):189-92. [Medline].

  38. Mydin AR, Armstrong JG. Acneiform rash secondary to cetuximab plus head and neck radiotherapy. Radiother Oncol. Oct 2007;85(1):171. [Medline].

  39. Neubert U, Jansen T, Plewig G. Bacteriologic and immunologic aspects of gram-negative folliculitis: a study of 46 patients. Int J Dermatol. Apr 1999;38(4):270-4. [Medline].

  40. Prose NS, Milburn PB, Papayanopulos DM. Facial sporotrichosis in children. Pediatr Dermatol. Sep 1986;3(4):311-4. [Medline].

  41. Rattana-Apiromyakij N, Kullavanijaya P. Eosinophilic pustular folliculitis: report of seven cases in Thailand. J Dermatol. Mar 2000;27(3):195-203. [Medline].

  42. Rosenberger A, Tebbe B, Treudler R, Orfanos CE. [Acute generalized exanthematous pustulosis, induced by nystatin]. Hautarzt. Jun 1998;49(6):492-5. [Medline].

  43. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. Sep 1991;127(9):1333-8. [Medline].

  44. Schwartz RA, Lamberts RJ. Isolated nodular cutaneous coccidioidomycosis. The initial manifestation of disseminated disease. J Am Acad Dermatol. Jan 1981;4(1):38-46. [Medline].

  45. Sun G, Wasko CA, Hsu S. Acneiform eruption following anti-TNF-alpha treatment: a report of three cases. J Drugs Dermatol. Jan 2008;7(1):69-71. [Medline].

  46. Tindall JP. Chloracne and chloracnegens. J Am Acad Dermatol. Oct 1985;13(4):539-58. [Medline].

  47. Warthan MM, Jumper CA, Smith JL. Acneiform eruption induced by Iressa (gefitinib) tablets used to treat non-small cell lung cancer. J Drugs Dermatol. Sep-Oct 2004;3(5):569-70. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.